Acotec Scientific Holdings Limited (SEHK: 6669)
Health Care · Health Care Equipment & Supplies · CN
HK$6.69
-13.13% today · -42.8% 1Y
Acotec Scientific Holdings Limited (SEHK: 6669) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $266.97M and employs 653 people.
Over the last twelve months the share price has lost 42.8%, trading between 6.16 and 15.47.
Tweenvest scores Acotec Scientific Holdings Limited across four factors: quality 68/100, value 74/100, growth 89/100. Its strongest factor is growth.
6669 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $266.97M
- Revenue (TTM)
- $92.16M
- P/E
- 15.40
- EPS
- 0.39
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- HK$15.47
- 52-week low
- HK$6.16
- Avg volume (3M)
- —
- Shares outstanding
- 313.39M
- Employees
- 653
- Next earnings
- —
About Acotec Scientific Holdings Limited
Acotec Scientific Holdings Limited is a medical technology firm specializing in the research and development of percutaneous transluminal angioplasty (PTA) and drug-coated balloon devices. These innovative products are designed to address various vascular diseases across Mainland China, Europe, and international markets. One key product, AcoArt Orchid & Dhalia, is developed to prevent the narrowing or blockage of superficial femoral and popliteal arteries, offering a treatment for lower extremity artery disease. This product is also currently undergoing clinical trials for additional applications, including arteriovenous fistula stenosis in nephrology, vertebral atherosclerotic stenosis in neurology, and vasculogenic erectile dysfunction in andrology. Another offering, AcoArt Tulip & Litos, is in the process of registration in China and Europe. Furthermore, it is under preclinical evaluation in the United States for treating below-the-knee artery disease within vascular surgery, and also for vasculogenic erectile dysfunction in andrology. The company was founded in 2020 and is headquartered in Beijing, China. Acotec Scientific Holdings Limited operates as a subsidiary of CA Medtech Investment (Cayman) Limited.
- ISIN
- KYG0096M1096
- Founded
- 2011
- Listed since
- Aug 24, 2021
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $197.44B | $114.10 | -1.75% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $130.86B | $370.42 | -0.38% |
| Stryker CorporationNYSE: SYK | $126.45B | $329.67 | -0.28% |
| Medtronic plcNYSE: MDT | $117.78B | $92.02 | +0.97% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.25B | €159.20 | +0.03% |
| Boston Scientific CorporationNYSE: BSX | $69.81B | $48.17 | -3.39% |
| HOYA CorporationTSE: 7741 | $52.40B | ¥24,965.00 | -0.12% |
| Edwards Lifesciences CorporationNYSE: EW | $52.33B | $90.78 | -0.10% |
Figures last refreshed Aug 18, 2026.